Selected research
Market Structure
Global Wearable Injectors and Connected Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Wearable Injectors and Connected Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Wearable Injectors and Connected Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Wearable Injectors and Connected Devices include Roche, Ypsomed, West Pharma, United Therapeutics, Unilife Corporation, Sonceboz, ScPharmaceuticals, Owen Mumford and Noble International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Wearable Injectors and Connected Devices market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Wearable Injectors and Connected Devices and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Wearable Injectors and Connected Devices sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Wearable Injectors and Connected Devices market size, projected growth trends, production technologies, key applications, and end-use industries.
Wearable Injectors and Connected Devices Segment by Company
Roche
Ypsomed
West Pharma
United Therapeutics
Unilife Corporation
Sonceboz
ScPharmaceuticals
Owen Mumford
Noble International
Insulet
Gerresheimer
Enable Injections
Elcam Medical
Eitan Medical
CeQur
BD Medical
Amgen
Wearable Injectors and Connected Devices Segment by Type
Disposable
Reusable
Wearable Injectors and Connected Devices Segment by Application
Home Care Settings
Hospitals
Clinics
Others
Wearable Injectors and Connected Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wearable Injectors and Connected Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wearable Injectors and Connected Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wearable Injectors and Connected Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Wearable Injectors and Connected Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Wearable Injectors and Connected Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Wearable Injectors and Connected Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Wearable Injectors and Connected Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Wearable Injectors and Connected Devices Industry Trends
Table 2. Wearable Injectors and Connected Devices Industry Drivers
Table 3. Wearable Injectors and Connected Devices Industry Opportunities and Challenges
Table 4. Wearable Injectors and Connected Devices Industry Restraints
Table 5. Global Wearable Injectors and Connected Devices Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Wearable Injectors and Connected Devices Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Wearable Injectors and Connected Devices Sales by Manufacturers (k units) & (2021-2026)
Table 8. Global Wearable Injectors and Connected Devices Sales Market Share by Manufacturers
Table 9. Global Wearable Injectors and Connected Devices Average Sales Price (USD/unit) of Manufacturers (2021-2026)
Table 10. Global Wearable Injectors and Connected Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Wearable Injectors and Connected Devices Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Wearable Injectors and Connected Devices Manufacturers, Product Type & Application
Table 13. Global Wearable Injectors and Connected Devices Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Wearable Injectors and Connected Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Disposable
Table 17. Major Manufacturers of Reusable
Table 18. Global Wearable Injectors and Connected Devices Sales by Type 2021 VS 2025 VS 2032 (k units)
Table 19. Global Wearable Injectors and Connected Devices Sales by Type (2021-2026) & (k units)
Table 20. Global Wearable Injectors and Connected Devices Sales by Type (2027-2032) & (k units)
Table 21. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2026)
Table 22. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2027-2032)
Table 23. Global Wearable Injectors and Connected Devices Revenue by Type 2021 VS 2025 VS 2032 (k units)
Table 24. Global Wearable Injectors and Connected Devices Revenue by Type (2021-2026) & (k units)
Table 25. Global Wearable Injectors and Connected Devices Revenue by Type (2027-2032) & (k units)
Table 26. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2026)
Table 27. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2027-2032)
Table 28. Major Manufacturers of Home Care Settings
Table 29. Major Manufacturers of Hospitals
Table 30. Major Manufacturers of Clinics
Table 31. Major Manufacturers of Others
Table 32. Global Wearable Injectors and Connected Devices Sales by Application 2021 VS 2025 VS 2032 (k units)
Table 33. Global Wearable Injectors and Connected Devices Sales by Application (2021-2026) & (k units)
Table 34. Global Wearable Injectors and Connected Devices Sales by Application (2027-2032) & (k units)
Table 35. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2026)
Table 36. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2027-2032)
Table 37. Global Wearable Injectors and Connected Devices Revenue by Application 2021 VS 2025 VS 2032 (k units)
Table 38. Global Wearable Injectors and Connected Devices Revenue by Application (2021-2026) & (k units)
Table 39. Global Wearable Injectors and Connected Devices Revenue by Application (2027-2032) & (k units)
Table 40. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2026)
Table 41. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2027-2032)
Table 42. Global Wearable Injectors and Connected Devices Sales by Region: 2021 VS 2025 VS 2032 (k units)
Table 43. Global Wearable Injectors and Connected Devices Sales by Region (2021-2026) & (k units)
Table 44. Global Wearable Injectors and Connected Devices Sales Market Share by Region (2021-2026)
Table 45. Global Wearable Injectors and Connected Devices Sales Forecasted by Region (2027-2032) & (k units)
Table 46. Global Wearable Injectors and Connected Devices Sales Forecasted Market Share by Region (2027-2032)
Table 47. North America Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 48. North America Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 49. North America Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 50. Europe Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 51. Europe Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 52. Europe Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 53. Asia Pacific Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 54. Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 55. Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 56. South America, Middle East and Africa Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units)
Table 57. South America, Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2021-2026) & (k units)
Table 58. South America, Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2027-2032) & (k units)
Table 59. Global Wearable Injectors and Connected Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 60. Global Wearable Injectors and Connected Devices Revenue by Region (2021-2026) & (US$ Million)
Table 61. Global Wearable Injectors and Connected Devices Revenue by Region (2027-2032) & (US$ Million)
Table 62. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2021-2026)
Table 63. Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2027-2032)
Table 64. Roche Company Information
Table 65. Roche Business Overview
Table 66. Roche Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. Roche Wearable Injectors and Connected Devices Product Portfolio
Table 68. Roche Recent Development
Table 69. Ypsomed Company Information
Table 70. Ypsomed Business Overview
Table 71. Ypsomed Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. Ypsomed Wearable Injectors and Connected Devices Product Portfolio
Table 73. Ypsomed Recent Development
Table 74. West Pharma Company Information
Table 75. West Pharma Business Overview
Table 76. West Pharma Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. West Pharma Wearable Injectors and Connected Devices Product Portfolio
Table 78. West Pharma Recent Development
Table 79. United Therapeutics Company Information
Table 80. United Therapeutics Business Overview
Table 81. United Therapeutics Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
Table 83. United Therapeutics Recent Development
Table 84. Unilife Corporation Company Information
Table 85. Unilife Corporation Business Overview
Table 86. Unilife Corporation Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
Table 88. Unilife Corporation Recent Development
Table 89. Sonceboz Company Information
Table 90. Sonceboz Business Overview
Table 91. Sonceboz Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 92. Sonceboz Wearable Injectors and Connected Devices Product Portfolio
Table 93. Sonceboz Recent Development
Table 94. ScPharmaceuticals Company Information
Table 95. ScPharmaceuticals Business Overview
Table 96. ScPharmaceuticals Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 97. ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
Table 98. ScPharmaceuticals Recent Development
Table 99. Owen Mumford Company Information
Table 100. Owen Mumford Business Overview
Table 101. Owen Mumford Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 102. Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
Table 103. Owen Mumford Recent Development
Table 104. Noble International Company Information
Table 105. Noble International Business Overview
Table 106. Noble International Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 107. Noble International Wearable Injectors and Connected Devices Product Portfolio
Table 108. Noble International Recent Development
Table 109. Insulet Company Information
Table 110. Insulet Business Overview
Table 111. Insulet Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 112. Insulet Wearable Injectors and Connected Devices Product Portfolio
Table 113. Insulet Recent Development
Table 114. Gerresheimer Company Information
Table 115. Gerresheimer Business Overview
Table 116. Gerresheimer Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 117. Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
Table 118. Gerresheimer Recent Development
Table 119. Enable Injections Company Information
Table 120. Enable Injections Business Overview
Table 121. Enable Injections Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 122. Enable Injections Wearable Injectors and Connected Devices Product Portfolio
Table 123. Enable Injections Recent Development
Table 124. Elcam Medical Company Information
Table 125. Elcam Medical Business Overview
Table 126. Elcam Medical Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 127. Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
Table 128. Elcam Medical Recent Development
Table 129. Eitan Medical Company Information
Table 130. Eitan Medical Business Overview
Table 131. Eitan Medical Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 132. Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
Table 133. Eitan Medical Recent Development
Table 134. CeQur Company Information
Table 135. CeQur Business Overview
Table 136. CeQur Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 137. CeQur Wearable Injectors and Connected Devices Product Portfolio
Table 138. CeQur Recent Development
Table 139. BD Medical Company Information
Table 140. BD Medical Business Overview
Table 141. BD Medical Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 142. BD Medical Wearable Injectors and Connected Devices Product Portfolio
Table 143. BD Medical Recent Development
Table 144. Amgen Company Information
Table 145. Amgen Business Overview
Table 146. Amgen Wearable Injectors and Connected Devices Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 147. Amgen Wearable Injectors and Connected Devices Product Portfolio
Table 148. Amgen Recent Development
Table 149. Key Raw Materials
Table 150. Raw Materials Key Suppliers
Table 151. Wearable Injectors and Connected Devices Distributors List
Table 152. Wearable Injectors and Connected Devices Customers List
Table 153. Research Programs/Design for This Report
Table 154. Authors List of This Report
Table 155. Secondary Sources
Table 156. Primary Sources
List of Figures
Figure 1. Wearable Injectors and Connected Devices Product Image
Figure 2. Global Wearable Injectors and Connected Devices Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Wearable Injectors and Connected Devices Market Size (2021-2032) & (US$ Million)
Figure 4. Global Wearable Injectors and Connected Devices Sales (2021-2032) & (k units)
Figure 5. Global Wearable Injectors and Connected Devices Average Price (USD/unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Wearable Injectors and Connected Devices Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Disposable Image
Figure 9. Reusable Image
Figure 10. Global Wearable Injectors and Connected Devices Sales by Type (2021 VS 2025 VS 2032) & (k units)
Figure 11. Global Wearable Injectors and Connected Devices Sales Market Share 2021 VS 2025 VS 2032
Figure 12. Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032)
Figure 13. Global Wearable Injectors and Connected Devices Revenue by Type (2021 VS 2025 VS 2032) & (k units)
Figure 14. Global Wearable Injectors and Connected Devices Revenue Market Share 2021 VS 2025 VS 2032
Figure 15. Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032)
Figure 16. Home Care Settings Image
Figure 17. Hospitals Image
Figure 18. Clinics Image
Figure 19. Others Image
Figure 20. Global Wearable Injectors and Connected Devices Sales by Application (2021 VS 2025 VS 2032) & (k units)
Figure 21. Global Wearable Injectors and Connected Devices Sales Market Share 2021 VS 2025 VS 2032
Figure 22. Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032)
Figure 23. Global Wearable Injectors and Connected Devices Revenue by Application (2021 VS 2025 VS 2032) & (k units)
Figure 24. Global Wearable Injectors and Connected Devices Revenue Market Share 2021 VS 2025 VS 2032
Figure 25. Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032)
Figure 26. North America Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 27. North America Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 28. U.S. Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 29. Canada Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 30. Mexico Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 31. Europe Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 32. Europe Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 33. Germany Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 34. France Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 35. U.K. Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 36. Italy Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 37. Netherlands Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 38. Asia Pacific Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 39. Asia Pacific Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 40. China Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 41. Japan Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 42. South Korea Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 43. Southeast Asia Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 44. India Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 45. Australia Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 46. South America, Middle East and Africa Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 47. South America, Middle East and Africa Wearable Injectors and Connected Devices Sales Market Share by Country (2021-2032)
Figure 48. Brazil Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 49. South Africa Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 50. Saudi Arabia Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 51. Turkey Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 52. Argentina Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 53. UAE Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 54. Egypt Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 55. Chile Wearable Injectors and Connected Devices Sales and Growth Rate (2021-2032) & (k units)
Figure 56. Global Wearable Injectors and Connected Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 57. Global Wearable Injectors and Connected Devices Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 58. North America Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million)
Figure 59. North America Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 60. Europe Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million)
Figure 61. Europe Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 62. Asia-Pacific Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million)
Figure 63. Asia-Pacific Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 64. South America, Middle East and Africa Wearable Injectors and Connected Devices Revenue (2021-2032) & (US$ Million)
Figure 65. South America, Middle East and Africa Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 66. Wearable Injectors and Connected Devices Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Wearable Injectors and Connected Devices Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
Scope & coverage.
Types
- Disposable
- Reusable
Applications
- Home Care Settings
- Hospitals
- Clinics
- Others
Companies covered
- Roche
- Ypsomed
- West Pharma
- United Therapeutics
- Unilife Corporation
- Sonceboz
- ScPharmaceuticals
- Owen Mumford
- Noble International
- Insulet
- Gerresheimer
- Enable Injections
- Elcam Medical
- Eitan Medical
- CeQur
- BD Medical
- Amgen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Wearable Injectors and Connected Devices Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Wearable Injectors and Connected Devices Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Wearable Injectors and Connected Devices Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Wearable Injectors and Connected Devices Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Wearable Injectors and Connected Devices Market Dynamics
- 2.1 Wearable Injectors and Connected Devices Industry Trends
- 2.2 Wearable Injectors and Connected Devices Industry Drivers
- 2.3 Wearable Injectors and Connected Devices Industry Opportunities and Challenges
- 2.4 Wearable Injectors and Connected Devices Industry Restraints
3 Wearable Injectors and Connected Devices Market by Manufacturers
- 3.1 Global Wearable Injectors and Connected Devices Revenue by Manufacturers (2021-2026)
- 3.2 Global Wearable Injectors and Connected Devices Sales by Manufacturers (2021-2026)
- 3.3 Global Wearable Injectors and Connected Devices Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Wearable Injectors and Connected Devices Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Wearable Injectors and Connected Devices Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Wearable Injectors and Connected Devices Manufacturers, Product Type & Application
- 3.7 Global Wearable Injectors and Connected Devices Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Wearable Injectors and Connected Devices Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Wearable Injectors and Connected Devices Players Market Share by Revenue in 2025
- 3.8.3 2025 Wearable Injectors and Connected Devices Tier 1, Tier 2, and Tier 3
4 Wearable Injectors and Connected Devices Market by Type
- 4.1 Wearable Injectors and Connected Devices Type Introduction
- 4.1.1 Disposable
- 4.1.2 Reusable
- 4.2 Global Wearable Injectors and Connected Devices Sales by Type
- 4.2.1 Global Wearable Injectors and Connected Devices Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Wearable Injectors and Connected Devices Sales by Type (2021-2032)
- 4.2.3 Global Wearable Injectors and Connected Devices Sales Market Share by Type (2021-2032)
- 4.3 Global Wearable Injectors and Connected Devices Revenue by Type
- 4.3.1 Global Wearable Injectors and Connected Devices Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Wearable Injectors and Connected Devices Revenue by Type (2021-2032)
- 4.3.3 Global Wearable Injectors and Connected Devices Revenue Market Share by Type (2021-2032)
5 Wearable Injectors and Connected Devices Market by Application
- 5.1 Wearable Injectors and Connected Devices Application Introduction
- 5.1.1 Home Care Settings
- 5.1.2 Hospitals
- 5.1.3 Clinics
- 5.1.4 Others
- 5.2 Global Wearable Injectors and Connected Devices Sales by Application
- 5.2.1 Global Wearable Injectors and Connected Devices Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Wearable Injectors and Connected Devices Sales by Application (2021-2032)
- 5.2.3 Global Wearable Injectors and Connected Devices Sales Market Share by Application (2021-2032)
- 5.3 Global Wearable Injectors and Connected Devices Revenue by Application
- 5.3.1 Global Wearable Injectors and Connected Devices Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Wearable Injectors and Connected Devices Revenue by Application (2021-2032)
- 5.3.3 Global Wearable Injectors and Connected Devices Revenue Market Share by Application (2021-2032)
6 Global Wearable Injectors and Connected Devices Sales by Region
- 6.1 Global Wearable Injectors and Connected Devices Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Wearable Injectors and Connected Devices Sales by Region (2021-2032)
- 6.2.1 Global Wearable Injectors and Connected Devices Sales by Region (2021-2026)
- 6.2.2 Global Wearable Injectors and Connected Devices Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Wearable Injectors and Connected Devices Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Wearable Injectors and Connected Devices Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Wearable Injectors and Connected Devices Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Wearable Injectors and Connected Devices Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Wearable Injectors and Connected Devices Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Wearable Injectors and Connected Devices Revenue by Region
- 7.1 Global Wearable Injectors and Connected Devices Revenue by Region
- 7.1.1 Global Wearable Injectors and Connected Devices Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Wearable Injectors and Connected Devices Revenue by Region (2021-2026)
- 7.1.3 Global Wearable Injectors and Connected Devices Revenue by Region (2027-2032)
- 7.1.4 Global Wearable Injectors and Connected Devices Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Wearable Injectors and Connected Devices Revenue (2021-2032)
- 7.2.2 North America Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Wearable Injectors and Connected Devices Revenue (2021-2032)
- 7.3.2 Europe Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Wearable Injectors and Connected Devices Revenue (2021-2032)
- 7.4.2 Asia-Pacific Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Wearable Injectors and Connected Devices Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Wearable Injectors and Connected Devices Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Roche
- 8.1.1 Roche Company Information
- 8.1.2 Roche Business Overview
- 8.1.3 Roche Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Roche Wearable Injectors and Connected Devices Product Portfolio
- 8.1.5 Roche Recent Developments
- 8.2 Ypsomed
- 8.2.1 Ypsomed Company Information
- 8.2.2 Ypsomed Business Overview
- 8.2.3 Ypsomed Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Ypsomed Wearable Injectors and Connected Devices Product Portfolio
- 8.2.5 Ypsomed Recent Developments
- 8.3 West Pharma
- 8.3.1 West Pharma Company Information
- 8.3.2 West Pharma Business Overview
- 8.3.3 West Pharma Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 West Pharma Wearable Injectors and Connected Devices Product Portfolio
- 8.3.5 West Pharma Recent Developments
- 8.4 United Therapeutics
- 8.4.1 United Therapeutics Company Information
- 8.4.2 United Therapeutics Business Overview
- 8.4.3 United Therapeutics Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 United Therapeutics Wearable Injectors and Connected Devices Product Portfolio
- 8.4.5 United Therapeutics Recent Developments
- 8.5 Unilife Corporation
- 8.5.1 Unilife Corporation Company Information
- 8.5.2 Unilife Corporation Business Overview
- 8.5.3 Unilife Corporation Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Unilife Corporation Wearable Injectors and Connected Devices Product Portfolio
- 8.5.5 Unilife Corporation Recent Developments
- 8.6 Sonceboz
- 8.6.1 Sonceboz Company Information
- 8.6.2 Sonceboz Business Overview
- 8.6.3 Sonceboz Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sonceboz Wearable Injectors and Connected Devices Product Portfolio
- 8.6.5 Sonceboz Recent Developments
- 8.7 ScPharmaceuticals
- 8.7.1 ScPharmaceuticals Company Information
- 8.7.2 ScPharmaceuticals Business Overview
- 8.7.3 ScPharmaceuticals Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 ScPharmaceuticals Wearable Injectors and Connected Devices Product Portfolio
- 8.7.5 ScPharmaceuticals Recent Developments
- 8.8 Owen Mumford
- 8.8.1 Owen Mumford Company Information
- 8.8.2 Owen Mumford Business Overview
- 8.8.3 Owen Mumford Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Owen Mumford Wearable Injectors and Connected Devices Product Portfolio
- 8.8.5 Owen Mumford Recent Developments
- 8.9 Noble International
- 8.9.1 Noble International Company Information
- 8.9.2 Noble International Business Overview
- 8.9.3 Noble International Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Noble International Wearable Injectors and Connected Devices Product Portfolio
- 8.9.5 Noble International Recent Developments
- 8.10 Insulet
- 8.10.1 Insulet Company Information
- 8.10.2 Insulet Business Overview
- 8.10.3 Insulet Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Insulet Wearable Injectors and Connected Devices Product Portfolio
- 8.10.5 Insulet Recent Developments
- 8.11 Gerresheimer
- 8.11.1 Gerresheimer Company Information
- 8.11.2 Gerresheimer Business Overview
- 8.11.3 Gerresheimer Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Gerresheimer Wearable Injectors and Connected Devices Product Portfolio
- 8.11.5 Gerresheimer Recent Developments
- 8.12 Enable Injections
- 8.12.1 Enable Injections Company Information
- 8.12.2 Enable Injections Business Overview
- 8.12.3 Enable Injections Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Enable Injections Wearable Injectors and Connected Devices Product Portfolio
- 8.12.5 Enable Injections Recent Developments
- 8.13 Elcam Medical
- 8.13.1 Elcam Medical Company Information
- 8.13.2 Elcam Medical Business Overview
- 8.13.3 Elcam Medical Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Elcam Medical Wearable Injectors and Connected Devices Product Portfolio
- 8.13.5 Elcam Medical Recent Developments
- 8.14 Eitan Medical
- 8.14.1 Eitan Medical Company Information
- 8.14.2 Eitan Medical Business Overview
- 8.14.3 Eitan Medical Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Eitan Medical Wearable Injectors and Connected Devices Product Portfolio
- 8.14.5 Eitan Medical Recent Developments
- 8.15 CeQur
- 8.15.1 CeQur Company Information
- 8.15.2 CeQur Business Overview
- 8.15.3 CeQur Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 CeQur Wearable Injectors and Connected Devices Product Portfolio
- 8.15.5 CeQur Recent Developments
- 8.16 BD Medical
- 8.16.1 BD Medical Company Information
- 8.16.2 BD Medical Business Overview
- 8.16.3 BD Medical Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 BD Medical Wearable Injectors and Connected Devices Product Portfolio
- 8.16.5 BD Medical Recent Developments
- 8.17 Amgen
- 8.17.1 Amgen Company Information
- 8.17.2 Amgen Business Overview
- 8.17.3 Amgen Wearable Injectors and Connected Devices Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Amgen Wearable Injectors and Connected Devices Product Portfolio
- 8.17.5 Amgen Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Wearable Injectors and Connected Devices Value Chain Analysis
- 9.1.1 Wearable Injectors and Connected Devices Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Wearable Injectors and Connected Devices Production Mode & Process
- 9.2 Wearable Injectors and Connected Devices Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Wearable Injectors and Connected Devices Distributors
- 9.2.3 Wearable Injectors and Connected Devices Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst